XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Investments
12 Months Ended
Dec. 31, 2022
Investments [Abstract]  
Investments INVESTMENTS
Money Market Investments. As of December 31, 2022, the Company had money market investments of $7.7 million that are classified as cash and cash equivalents in the Company’s Consolidated Balance Sheets. The Company had no money market investments as of December 31, 2021.
Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
As of December 31
(in thousands)
20222021
Total cost
$270,764 $273,201 
Gross unrealized gains
363,147 537,915 
Gross unrealized losses(23,990)(1,119)
Total Fair Value
$609,921 $809,997 
At December 31, 2022 and 2021, the Company owned 55,430 and 44,430 shares, respectively, in Markel Corporation (Markel) valued at $73.0 million and $54.8 million, respectively. The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of December 31, 2022, the Company owned 422 Class A and 482,945 Class B shares in Berkshire Hathaway valued at $347.0 million, which exceeded 5% of the Company’s total assets.
The Company purchased $42.1 million, of which $1.5 million was settled in January 2023, $48.0 million and $20.0 million of marketable equity securities during 2022, 2021 and 2020, respectively.
During 2022, 2021 and 2020, the gross cumulative realized net gains from the sales of marketable equity securities were $58.1 million, $46.0 million and $23.0 million, respectively. The total proceeds from such sales were $102.0 million, $65.5 million and $93.8 million, respectively.
The net (loss) gain on marketable equity securities comprised the following:
Year Ended December 31
(in thousands)
202220212020
(Loss) gain on marketable equity securities, net
$(139,589)$243,088 

$60,787 
Less: Net losses (gains) in earnings from marketable equity securities sold and donated
27,786 (17,830)13,382 
Net unrealized (losses) gains in earnings from marketable equity securities still held at the end of the year
$(111,803)

$225,258 

$74,169 
Investments in Affiliates. As of December 31, 2022, the Company held a 49.9% interest in N2K Networks on a fully diluted basis, and accounts for its investment under the equity method. The Company holds two of the five seats of N2K Networks’ governing board with the other shareholders retaining substantive participation rights to control the financial and operating decisions of N2K Networks through their representation on the board.
As of December 31, 2022, the Company held an approximate 12% interest in Intersection Holdings, LLC (Intersection), and accounts for its investment under the equity method. The Company holds two of the ten seats of Intersection’s governing board, which allows the Company to exercise significant influence over Intersection.
As of December 31, 2022, the Company also held investments in several other affiliates; GHG held a 40% interest in Residential Home Health Illinois, a 40% interest in Residential Hospice Illinois, a 40% interest in the joint venture formed between GHG and a Michigan hospital, and a 40% interest in the joint venture formed between GHG and Allegheny Health Network (AHN). During the first quarter of 2022, GHG invested an additional $18.5 million in the Residential Home Health Illinois and Residential Hospice Illinois affiliates to fund their acquisition of certain home health and hospice assets of the NorthShore University HealthSystem. The transaction diluted GHG’s interest in
Residential Hospice Illinois resulting in a $0.6 million gain on sale of investment in affiliate (see Note 16). For the years ended December 31, 2022, 2021 and 2020, GHG recorded $13.9 million, $10.9 million and $9.6 million, respectively, in revenue for services provided to its affiliates.
The Company had $49.1 million and $52.5 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of December 31, 2022 and 2021, respectively.
In the third quarter of 2021, the Company recorded an impairment charge of $6.6 million on one of its investments in affiliates as a result of the challenging economic environment for this business following an announcement by the Chinese government to reform the education sector for private education companies. In the first quarter of 2020, the Company recorded impairment charges of $3.6 million on two of its investments in affiliates as a result of the challenging economic environment for these businesses, of which $2.7 million related to the Company’s investment in Framebridge.
In May 2020, the Company made an additional investment in Framebridge (see Note 3) that resulted in the Company obtaining control of the investee. The results of operations, cash flows, assets and liabilities of Framebridge are included in the consolidated financial statements of the Company from the date of the acquisition. Timothy J. O’Shaughnessy, President and Chief Executive Officer of Graham Holdings Company, was a personal investor in Framebridge and served as Chairman of the Board prior to the acquisition of the additional interest. The Company acquired Mr. O’Shaughnessy’s interest under the same terms as the other Framebridge investors.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which loan is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £20.4 million as of December 31, 2022. The loan is repayable by December 2041.
Summarized Financial Data of Nonconsolidated Affiliates. The Company’s investments in affiliates consists of investments in private equity funds and other operating entities that it does not control, but over which it exerts significant influence. The following tables present summarized financial data for the Company’s nonconsolidated affiliates. The amounts included in the tables below present 100% of the balance sheets and the results of operations of such nonconsolidated affiliates accounted for under the equity method.
The Company’s ownership in private equity fund partnerships varies between approximately 4% and 10%; the Company’s related investment balance included in Investments in Affiliates was $68.9 million and $72.8 million as of December 31, 2022 and 2021, respectively.
The summarized balance sheet data of the private equity fund investments consists of the following:
As of December 31
(in thousands)
20222021
Investments in securities, at estimated fair value
$1,974,189 $2,039,368 
Other current assets
19,072 28,590 
Total assets
$1,993,261 $2,067,958 
Total liabilities
$3,945 $4,790 
Total partners’ capital
1,989,316 2,063,168 
Total liabilities and partners’ capital
$1,993,261 $2,067,958 
The summarized operating data of the private equity fund investments was as follows:
Year Ended December 31
(in thousands)
202220212020
Net investment loss
$(14,129)$(13,324)$(15,301)
Net realized gain on investments
162,644 190,368 440 
Net change in unrealized (depreciation) appreciation on investments
(66,333)1,043,627 525,588 
Increase in net assets from operations
$82,182 $1,220,671 $510,727 
The summarized balance sheet data of the operating entity investments consists of the following:
As of December 31
(in thousands)
20222021
Current assets
$174,027 $203,274 
Noncurrent assets
542,625 569,505 
Total assets
$716,652 $772,779 
Current liabilities
$126,365 $219,220 
Noncurrent liabilities
386,425 329,965 
Total liabilities
$512,790 $549,185 
Noncontrolling interests
$(26,593)$(80,604)
The summarized operating data of the operating entity investments was as follows:
Year Ended December 31
(in thousands)
202220212020
Net sales
$459,949 $358,928 $312,194 
Gross profit
196,481 146,312 11,217 
Net income (loss)
3,206 135,241 (206,504)
Net income (loss) attributable to the entity
5,124 102,829 (148,394)
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $66.7 million and $48.9 million as of December 31, 2022 and 2021, respectively. During the years ended December 31, 2022, 2021 and 2020, the Company recorded gains of $6.9 million, $11.8 million and $4.2 million, respectively, to those equity securities based on observable transactions. For the years ended December 31, 2022 and 2020, the Company recorded impairment losses of $1.3 million and $7.3 million, respectively, to those securities.